Moreover, a meta-analysis stipulated that the symptoms of depression could be controlled with Celecoxib, a non-steroidal anti-inflammatory drug (NSAID) presenting high COX-2 selectivity, without developing any serious side effects [45]. Here, PTGS2 is linked to depressive disorder.